Jane Street Group, LLC Homology Medicines, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.53 - $1.14 $12,533 - $26,959	23,649 New	23,649 $14,000
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $14,268 - $26,703	13,090 New	13,090 $16,000
Q1 2021 May 18, 2021	SELL	$9.17 - $14.8 $162,666 - $262,537	-17,739 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$8.92 - $13.29 $62,654 - $93,348	-7,024 Reduced 28.36%	17,739 $201,000
Q3 2020 Nov 17, 2020	BUY	$9.94 - $16.59 $246,144 - $410,818	24,763 New	24,763 $264,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.